Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Boehringer Ingelheim
Healthtrust
UBS
Dow
Medtronic
Chubb
Novartis
Citi

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040682

« Back to Dashboard

NDA 040682 describes BENZONATATE, which is a drug marketed by Apotex Inc, Bionpharma Inc, Cspc Nbp Pharm Co, Mikart, Nesher Pharms, Orit Labs Llc, Strides Pharma, Sun Pharm Inds Inc, The Pharma Network, Thepharmanetwork Llc, and Zydus Pharms Usa, and is included in twelve NDAs. It is available from fifty-seven suppliers. Additional details are available on the BENZONATATE profile page.

The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the benzonatate profile page.
Summary for 040682
Tradename:BENZONATATE
Applicant:Orit Labs Llc
Ingredient:benzonatate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 040682
Suppliers and Packaging for NDA: 040682
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENZONATATE benzonatate CAPSULE;ORAL 040682 ANDA Major Pharmaceuticals 0904-6254 0904-6254-60 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0904-6254-60)
BENZONATATE benzonatate CAPSULE;ORAL 040682 ANDA Marlex Pharmaceuticals Inc 10135-632 10135-632-05 500 CAPSULE in 1 BOTTLE (10135-632-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Jul 30, 2007TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Jul 30, 2007TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
US Department of Justice
Chinese Patent Office
Mallinckrodt
McKesson
Cantor Fitzgerald
Daiichi Sankyo
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot